ICD-10 Code D68.318 – Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors (2026): Diagnosis, Symptoms & Billing Guide
2026 ICD-10-CM Diagnosis Code D68.318 – Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
What it is
This code identifies a bleeding disorder caused by circulating anticoagulants, antibodies, or inhibitors that interfere with normal clotting. It is used when the documentation supports a hemorrhagic disorder related to an intrinsic inhibitor rather than another specific coagulopathy.
Clinical signs
Clinical features vary; refer to documentation. Patients may have easy bruising, mucosal bleeding, prolonged bleeding after injury, or other bleeding manifestations consistent with an acquired clotting inhibitor.
When to use this code
Use this code when the record documents a hemorrhagic disorder due to an intrinsic circulating anticoagulant, antibody, or inhibitor and no more specific ICD-10 code applies. It may fit cases described as an acquired inhibitor-related bleeding disorder. Check documentation for the exact cause and whether another coagulopathy code is more appropriate.
Do not use for
Do not use this code for routine anticoagulant therapy, medication-related bleeding, or unspecified bleeding without a documented inhibitor. Also avoid it when the condition is better described by a different coagulation disorder code.
Coding tip
Link the code to the documented cause of bleeding and verify that the provider identifies an intrinsic anticoagulant, antibody, or inhibitor.